| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.003 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |